Literature DB >> 24193696

The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles.

Anthony N Imudia1, Randi H Goldman, Awoniyi O Awonuga, Diane L Wright, Aaron K Styer, Thomas L Toth.   

Abstract

PURPOSE: To determine the impact of elevated serum estradiol levels (EE2-defined as levels > 90th percentile) on the day of hCG administration during IVF on oocyte fertilization, embryo development, implantation, clinical pregnancy and miscarriage rates.
METHODS: A total of 2,995 consecutive IVF cycles in 1,889 patients with non-donor oocyte retrieval resulting in fresh embryo transfer between 1/1/2005 and 12/31/2011 were analyzed. Cycles were stratified by serum E2 level on the day of hCG administration into those with levels >90th percentile and ≤ 90th percentile. Rates of normal fertilization, embryo development, positive pregnancy test, implantation, clinical pregnancy and spontaneous miscarriage were compared.
RESULTS: Serum estradiol above the 90th percentile on the day of hCG administration was associated with a significantly lower rate of normal fertilization (68.6 ± 20 vs. 71.6 ± 21, p = 0.02) when compared with patients with a lower serum estradiol threshold. The proportion of embryos that progressed from 2PN to 6-8 cell on day 3 was not different between the two groups. Although rates of positive pregnancy test (55.2 % vs. 57 %), implantation (26.4 % vs. 28.5 %) and clinical pregnancy (45.5 % vs. 49.4 %) were lower in patients with a higher estradiol threshold, these differences were not statistically significant. Similarly, there was no difference in the spontaneous miscarriage rates between the two groups (8.4 % vs. 7.1 %).
CONCLUSIONS: Serum estradiol levels above the 90th percentile on the day of hCG administration is associated with lower oocyte fertilization rate; however, such levels do not impact embryo development, implantation, clinical pregnancy or spontaneous miscarriage rates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24193696      PMCID: PMC3909127          DOI: 10.1007/s10815-013-0117-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  36 in total

1.  Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies.

Authors:  S L Tan; P Doyle; S Campbell; V Beral; B Rizk; P Brinsden; B Mason; R G Edwards
Journal:  Am J Obstet Gynecol       Date:  1992-09       Impact factor: 8.661

2.  Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).

Authors:  Qiu-Ju Chen; Xiao-Xi Sun; Lu Li; Xiao-Hong Gao; Yu Wu; Kristina Gemzell-Danielsson; Li-Nan Cheng
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

3.  High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome.

Authors:  F I Sharara; H D McClamrock
Journal:  Fertil Steril       Date:  1999-09       Impact factor: 7.329

4.  The influence of supraphysiologic estradiol levels on human nidation.

Authors:  T J Gelety; R P Buyalos
Journal:  J Assist Reprod Genet       Date:  1995-08       Impact factor: 3.412

5.  Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability.

Authors:  J Testart; J Belaisch-Allart; R Forman; A Gazengel; N Strubb; A Hazout; R Frydman
Journal:  Hum Reprod       Date:  1989-02       Impact factor: 6.918

6.  Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease.

Authors:  Aslan T Turer; Kenneth W Mahaffey; Emily Honeycutt; Robert H Tuttle; Linda K Shaw; Michael H Sketch; Peter K Smith; Robert M Califf; John H Alexander
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03-04       Impact factor: 5.209

7.  An aggressive philosophy in controlled ovarian stimulation cycles increases pregnancy rates.

Authors:  R J Gratton; J A Nisker; S Daniel; S Toth; J Gunter; B R Kaplan; I S Tummon; A A Yuzpe
Journal:  Hum Reprod       Date:  1993-04       Impact factor: 6.918

8.  Offspring of Prenatal IV Nicotine Exposure Exhibit Increased Sensitivity to the Reinforcing Effects of Methamphetamine.

Authors:  Steven B Harrod; Ryan T Lacy; Amanda J Morgan
Journal:  Front Pharmacol       Date:  2012-06-18       Impact factor: 5.810

9.  Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes.

Authors:  Duk-Hee Lee; Michael W Steffes; Andreas Sjödin; Richard S Jones; Larry L Needham; David R Jacobs
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

10.  Evaluating the Association between Assisted Conception and the Severity of Preeclampsia.

Authors:  Kathryn C Calhoun; Kurt T Barnhart; Michal A Elovitz; Sindhu K Srinivas
Journal:  ISRN Obstet Gynecol       Date:  2011-10-30
View more
  13 in total

1.  Frozen embryo transfer can be performed in the cycle immediately following the freeze-all cycle.

Authors:  Kemal Ozgur; Hasan Bulut; Murat Berkkanoglu; Peter Humaidan; Kevin Coetzee
Journal:  J Assist Reprod Genet       Date:  2017-09-22       Impact factor: 3.412

2.  Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology?

Authors:  Greene Donald Royster; Kavitha Krishnamoorthy; John M Csokmay; Belinda J Yauger; Rebecca J Chason; Alan H DeCherney; Erin F Wolff; Micah J Hill
Journal:  Fertil Steril       Date:  2016-05-10       Impact factor: 7.329

3.  Is the probability of pregnancy after ovarian stimulation for IVF associated with serum estradiol levels on the day of triggering final oocyte maturation with hCG? A systematic review and meta-analysis.

Authors:  Glykeria I Karatasiou; J K Bosdou; C A Venetis; L Zepiridis; K Chatzimeletiou; T B Tarlatzi; G Lainas; B C Tarlatzis; G Grimbizis; E M Kolibianakis
Journal:  J Assist Reprod Genet       Date:  2020-05-29       Impact factor: 3.412

4.  Association between serum estradiol level on day of progesterone start and outcomes from frozen blastocyst transfer cycles utilizing oral estradiol.

Authors:  Randi H Goldman; Anna Greer; Catherine Racowsky; Leslie V Farland; Andrea Lanes; Ann Muir Thomas; Mark D Hornstein
Journal:  J Assist Reprod Genet       Date:  2022-05-18       Impact factor: 3.357

5.  The effect of low-dose aspirin on the pregnancy rate in frozen-thawed embryo transfer cycles: A randomized clinical trial.

Authors:  Robab Davar; Soheila Pourmasumi; Banafsheh Mohammadi; Maryam Mortazavi Lahijani
Journal:  Int J Reprod Biomed       Date:  2020-09-20

Review 6.  Why we should transfer frozen instead of fresh embryos: the translational rationale.

Authors:  Rachel Weinerman; Monica Mainigi
Journal:  Fertil Steril       Date:  2014-06-02       Impact factor: 7.329

7.  The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle.

Authors:  Jigal Haas; Rawad Bassil; Noa Gonen; Jim Meriano; Andrea Jurisicova; Robert F Casper
Journal:  Reprod Biol Endocrinol       Date:  2018-05-29       Impact factor: 5.211

8.  Correlation between follicular fluid 25-OH vitamin D and assisted reproductive outcomes.

Authors:  Laya Farzadi; Homa Khayatzadeh Bidgoli; Morteza Ghojazadeh; Zahra Bahrami; Amir Fattahi; Zeinab Latifi; Vahideh Shahnazi; Mohammad Nouri
Journal:  Iran J Reprod Med       Date:  2015-06

9.  The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer.

Authors:  Xiao-Jin Zhang; Su-Ying Liu; Wei Fu; Xiao-Xi Sun
Journal:  Reprod Biol Endocrinol       Date:  2015-10-06       Impact factor: 5.211

10.  Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

Authors:  Jigal Haas; Rawad Bassil; Jim Meriano; Nivin Samara; Eran Barzilay; Noa Gonen; Robert F Casper
Journal:  Reprod Biol Endocrinol       Date:  2017-08-30       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.